LBCA Scientific Advisory Board Member Presents Research on Genetic Test for ILC Patients
Dr. Otto Metzger Discusses Genetic Test Identifying Patients with ILC at High Risk of Disease Recurrence A test that scans the activity of 70 genes […]
A Message from LBCA’s Founder
Dear LBCA Community, I am excited to share that LBCA has reached an important milestone, and I am thrilled to introduce you to the new
A Message from LBCA’s Founder Read More »
A Message from LBCA’s Executive Director
I am so happy to be LBCA’s new Executive Director and grateful to be able to help move this incredible organization created by Leigh Pate
A Message from LBCA’s Executive Director Read More »
Heard at Lynn Sage virtual Breast Cancer Symposium
Contrast Enhanced Mammography Being Assessed for Improved Efficacy in Detecting Tumors Including Lobular in Dense Breasts Maxine Jochelson, MD, is the Director of Imaging at
Heard at Lynn Sage virtual Breast Cancer Symposium Read More »
Dr. Simon Johnston Speaks to New ILC Research – What it Means and Its Potential Impact
In August, Breast Cancer Research published the study Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma:
Dr. Simon Johnston Speaks to New ILC Research – What it Means and Its Potential Impact Read More »
LBCA’s Scientific Advisory Board Is Tackling ILC through Research
The Lobular Breast Cancer Alliance keeps its invasive lobular carcinoma (ILC) information and research cutting edge with the guidance of a Scientific Advisory Board (SAB)
LBCA’s Scientific Advisory Board Is Tackling ILC through Research Read More »
